NLS Intellectual Property

Valo Therapeutics has announced the acquisition of intellectual property rights from the University of Helsinki for the technology which utilizes pre-existing immunity (PEI) against pathogens to enhance the therapeutic efficacy of ValoTx’s lead platform, PeptiCRAd. This approach takes advantage of existing acquired immunity (generated, for example, through vaccination against pathogens) by including pathogen specific peptides […]

Xbrane Biopharma has been granted four new patents by the Swedish Patent and Registration Office (PRV). The patents resulted from the development of Xdivane (an Opdivo biosimilar) and form the foundation for a broadening of the platform technology for the production of antibodies with high productivity and thereby low production costs in mammalian cells. This […]

The company has been granted a patent from the European Patent Office, covering the treatment of fungal infections with compound glucono-δ-lactone (GDL). The patent is valid in 36 European countries and can be kept in force until the 6th of April 2037. Gedea Biotech has previously announced that the corresponding patent is approved in the […]

Genetic Analysis has been awarded an important patent by the China National Intellectual Property Agency (CNIPA). The patent entitled “A method for determining gastrointestinal tract dysbiosis” covers the company’s algorithm incorporated in the GA-map technology for profiling gut microbiota. The positive decision from the Chinese patent authority means that the protection of the GA-map technology […]

Xbrane Biopharma has been granted two new patents by the Swedish patent and Registration Office (PRV). The patents relate to novel methods of using signal peptides to enhance the production yield and thereby lowering the production cost of recombinant proteins expressed in E.coli. The patents are an important additional component to Xbrane’s platform technology aimed […]

AdjuTec Pharma has announced the approval of ZinChel II in Europe (EPO). This is the most important patent family covering its lead product APC148, it states in a press release. The company has earlier received patent approval in the US and is working with the patent in other major markets including China and India. Read […]